A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of BION-1301 in Adults with IgA Nephropathy
Description
The medication is taken by injection every 2 weeks for two years.
Details
Age
Adult
Eligibility
Biopsy-proven IgAN within past 10 years; stable on ACEi/ARB for at least 12 weeks.
Type of Study
Treatment
Locations
Renal Research Center
Principal Investigator
James Dylewski, DO
Study ID
Protocol Number: 23-0695
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers